|
ATXN7L3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.250990E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.499900E-02 |
| Normal-vs-Stage2 |
3.875600E-01 |
| Normal-vs-Stage3 |
8.708000E-01 |
| Normal-vs-Stage4 |
4.516200E-01 |
| Stage1-vs-Stage2 |
5.716800E-01 |
| Stage1-vs-Stage3 |
5.222100E-02 |
| Stage1-vs-Stage4 |
4.106600E-01 |
| Stage2-vs-Stage3 |
4.376800E-01 |
| Stage2-vs-Stage4 |
8.584200E-01 |
| Stage3-vs-Stage4 |
5.404800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.416790E-01 |
| Normal-vs-AfricanAmerican |
1.193230E-01 |
| Normal-vs-Asian |
2.154200E-02 |
| Caucasian-vs-AfricanAmerican |
5.448400E-01 |
| Caucasian-vs-Asian |
8.972300E-02 |
| AfricanAmerican-vs-Asian |
5.638200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.609600E-01 |
| Normal-vs-Female |
1.239230E-01 |
| Male-vs-Female |
8.168800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.112200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.097400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.391200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.439400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.534800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.908060E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.799000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.639030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.325200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.986200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.801300E-03 |
| Classical-VS-Follicular |
8.28410000000002E-05 |
| Classical-VS-Other |
7.100800E-01 |
| Classical-VS-Normal |
1.253550E-02 |
| Tall-VS-Follicular |
8.682400E-01 |
| Tall-VS-Other |
2.764400E-01 |
| Tall-VS-Normal |
4.228600E-01 |
| Follicular-VS-Other |
3.920600E-01 |
| Follicular-VS-Normal |
4.812600E-01 |
| Other-VS-Normal |
4.902800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.711000E-01 |
| Normal-vs-N1 |
3.109800E-01 |
| N0-vs-N1 |
6.808600E-01 |
|
|
